Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG, Pao W, Ladanyi M, Miller VA. Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation. Clinical Cancer Research. 2011 Mar 15;17(6):1616-22.
Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. Journal of the American Medical Association (JAMA) 2010: 304 (14), pp. 1584-1591.
Sima CS, Panageas KS, Heller G, Schrag D. Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data. Applied Health Economics and Health Policy 2010: 8 (1), pp. 37-51
Sima CS, Jarnagin WR, Fong Y, Elkin E, Fischer M, Wuest D, D'Angelica M, DeMatteo RP, Blumgart LH, Gönen M. Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg. 2009 Dec;250(6):914-21.
Schaubel DE, Wolfe RA, Sima CS, Merion RM. Estimating the effect of a time-dependent treatment by levels of an internal time-dependent covariate: application to the contrast between liver wait-list and post-transplant mortality. Journal of the American Statistical Association (JASA). 2009 Mar; 104 (485): 49-59